A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study is being conducted as a regulatory requirement post initial marketing
authorization. This is primarily a safety study. This was an open label study and patients
were enrolled once the decision to prescribe the medication was made by the Investigator.
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.